Evidence map›Paper›PMID 31396997›Full record

ArticleJournal of gastroenterology and hepatology2020

Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett's esophagus.

Akira Yamasaki, Tomoki Shimizu, Hiroshi Kawachi, Noriko Yamamoto, Shoichi Yoshimizu, Yusuke Horiuchi, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Tomohiro Tsuchida and 2 more

Abstract read
In one paragraph

Article in Journal of gastroenterology and hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Akira YamasakiDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6125-9161
Tomoki ShimizuDepartment of Gastroenterology, Yokohama Sakae Kyosai Hospital, Yokohama, Japan.
Hiroshi KawachiDepartment of Pathology, Cancer Institute Hospital, Tokyo, Japan.
Noriko YamamotoDepartment of Pathology, Cancer Institute Hospital, Tokyo, Japan.
Shoichi YoshimizuDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Yusuke HoriuchiDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8116-8152
Akiyoshi IshiyamaDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Toshiyuki YoshioDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Toshiaki HirasawaDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Tomohiro TsuchidaDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Yutaka SasakiDepartment of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Junko FujisakiDepartment of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe study aims to clarify the endoscopic features and clinicopathological differences in superficial Barret's esophageal adenocarcinoma (s-BEA) derived from short-segment Barrett's esophagus (SSBE) and long-segment Barrett's esophagus (LSBE).

methodsWe reviewed data of 130 patients (141 lesions) with pathologically confirmed s-BEA (SSBE: 95 patients and 95 lesions; LSBE: 35 patients and 46 lesions). We analyzed endoscopic and clinicopathological features of s-BEA in patients with SSBE and LSBE.

resultsThe distribution of lesions according to macroscopic findings were as follows (s-BEA in SSBE vs LSBE): flat type (0-IIb), 3.2% (3/95) vs 32.6% (15/46) (P < 0.001); accompanied type 0-IIb, 2.1% (2/95) vs 21.7% (10/46) (P < 0.001); and complex type (0-I + IIb, 0-IIa + IIc, etc.), 30.5% (29/95) vs 50.0% (23/46) (P = 0.025). Complex-type s-BEAs had high incidences of T1b invasions and poorly differentiated components (simple type: 22.5% [20/89] and 18.0% [16/89]; complex type: 59.6% [31/52] and 44.2% [23/52], P < 0.001 and P = 0.002, respectively). In SSBE, 72.6% (69/95) of lesions were located at the right anterior wall (P = 0.01). All flat-type or depressed-type lesions derived from SSBE were identified as reddish areas, whereas only 65.2% (15/23) from LSBE were identified as reddish areas (P < 0.001).

conclusionsIn LSBE, flat-type, accompanied-type 0-IIb, and complex-type lesions were significantly more prevalent. Furthermore, complex-type s-BEAs tended to have T1b invasions and poorly differentiated components. S-BEAs in LSBE should be more carefully evaluated on endoscopic appearance including flat-type and complex-type lesions than in SSBE.

Indexed as

EndoscopyAdenocarcinomaAgedBarrett EsophagusEsophageal NeoplasmsEsophagusFemaleHumansMaleMiddle AgedRetrospective StudiesBarrett's esophagusesophageal adenocarcinomalong-segment Barrett's esophagusshort-segment Barrett's esophagussuperficial Barrett's esophageal adenocarcinoma

Identifiers

PMID31396997
PMCPMC7027738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.